Alerts will be sent to your verified email
Verify Email
ONYX
|
Onyx Biotec
|
Cohance Lifesciences
|
JB Chem & Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
13.47 % | 22.91 % | 19.49 % |
|
5yr average Equity Multiplier
|
2.51 | 1.35 | 1.52 |
|
5yr Average Asset Turnover Ratio
|
0.82 | 0.56 | 0.77 |
|
5yr Avg Net Profit Margin
|
6.72 % | 30.38 % | 16.71 % |
|
Price to Book
|
1.26 | 6.22 | 7.51 |
|
P/E
|
14.09 | 95.02 | 39.78 |
|
5yr Avg Cash Conversion Cycle
|
36.81 Days | 49.95 Days | 7.58 Days |
|
Inventory Days
|
48.71 Days | 74.21 Days | 50.33 Days |
|
Days Receivable
|
104.89 Days | 63.71 Days | 67.54 Days |
|
Days Payable
|
101.26 Days | 80.35 Days | 90.39 Days |
|
5yr Average Interest Coverage Ratio
|
4.89 | 49.87 | 58.81 |
|
5yr Avg ROCE
|
12.63 % | 27.5 % | 23.05 % |
|
5yr Avg Operating Profit Margin
|
14.14 % | 40.14 % | 24.73 % |
|
5 yr average Debt to Equity
|
0.95 | 0.06 | 0.07 |
|
5yr CAGR Net Profit
|
8.12 % | -5.86 % | 8.05 % |
|
5yr Average Return on Assets
|
5.64 % | 17.54 % | 12.98 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
65.1 % | 57.49 % | 47.56 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -2.51 % | -6.4 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 8.21 % | 3.75 % |
|
Onyx Biotec
|
Cohance Lifesciences
|
JB Chem & Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|